Aeterna Zentaris Reports Second Quarter 2023 Financial Results
Provided By GlobeNewswire
Last update: Aug 9, 2023
TORONTO, ONTARIO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today reported its financial and operating results for the quarter ended June 30, 2023.
Read more at globenewswire.com
